蓝帆医疗: 关于董事会提议向下修正蓝帆转债转股价格的公告

Core Viewpoint - The company proposes to lower the conversion price of its convertible bonds, "蓝帆转债," due to the stock price falling below 85% of the current conversion price for at least 15 out of 30 consecutive trading days [1][4]. Group 1: Convertible Bond Issuance and Adjustment - The total amount of the convertible bonds issued by the company is 314.404 million yuan, approved by the China Securities Regulatory Commission [1]. - The initial conversion price of "蓝帆转债" was set at 17.79 yuan per share, which was later adjusted to 18.64 yuan per share after the company repurchased and canceled 48,148,336 shares [2]. - The board of directors has decided to lower the conversion price to 12.50 yuan per share, effective from May 21, 2024 [3]. Group 2: Conditions for Price Adjustment - The adjustment of the conversion price is triggered when the company's stock price falls below 85% of the current conversion price for at least 15 trading days within a 30-day period [3][4]. - The adjusted conversion price must not be lower than the higher of the average stock price over the 20 trading days prior to the shareholders' meeting and the previous trading day's average price, as well as not lower than the latest audited net asset value per share and the par value of the stock [5]. Group 3: Shareholder Approval and Process - The proposal to adjust the conversion price requires approval from more than two-thirds of the voting rights held by shareholders present at the meeting, excluding those holding the convertible bonds [3][4]. - The company will publish the resolution of the shareholders' meeting, including the adjustment range, registration date, and any suspension of conversion [4].